Press release
Non-Hodgkin lymphoma Treatment Market Size in the 7MM is expected to grow by a significant CAGR by 2032, estimates DelveInsight | AbbVie, Genmab, Novartis, Angiocrine Bioscience, Autolus, Zentera Therapeutics, Jiangsu Hengrui Medicine
Non-Hodgkin's Lymphoma Market
Discover Key Insights into the Non-Hodgkin's Lymphoma Market with DelveInsight's In-Depth Report @ Non-Hodgkin's Lymphoma Market Size- https://www.delveinsight.com/sample-request/non-hodgkins-lymphoma-nhl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Non-Hodgkin's Lymphoma Market Report
• In February 2025:- Juventas Cell Therapy Ltd.- The study is a Phase II, single-arm, open-label, single-dose clinical trial, and its primary objective is to evaluate the efficacy and safety of CNCT19 Cell Injection in the treatment of relapsed or refractory NHL. The study consists of screening period (8 weeks), treatment period (4 weeks), and follow-up period (2 years at most).
• In February 2025:- Bristol-Myers Squibb:- The purpose of this study is to assess the safety, tolerability, drug levels, and preliminary efficacy of relatlimab plus nivolumab in pediatric and young adult participants with recurrent or refractory classical Hodgkin lymphoma and non-Hodgkin lymphoma.
• As per the American Cancer Society (2022), NHL is one of the most common cancers in the United States, accounting for about 4% of all cancers. About 80,470 people will be diagnosed with NHL in 2022.
• The leading Non-Hodgkin's Lymphoma Companies such as AbbVie, Genmab, Novartis, Angiocrine Bioscience, Autolus, Zentera Therapeutics, Jiangsu Hengrui Medicine, and others.
• Promising Non-Hodgkin's Lymphoma Therapies such as Tisagenlecleucel, AB-205, Epcoritamab, AUTO4, ZN-d5, HRS-3738, and others.
Stay ahead in the Non-Hodgkin's Lymphoma Therapeutics Market with DelveInsight's Strategic Report @ Non-Hodgkin's Lymphoma Market Outlook- https://www.delveinsight.com/sample-request/non-hodgkins-lymphoma-nhl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Non-Hodgkin lymphoma Epidemiology Segmentation in the 7MM
• Total Non-Hodgkin's Lymphoma Incident Cases
• Non-Hodgkin's Lymphoma Type-specific Incident Cases
• Non-Hodgkin's Lymphoma Stage-specific Incident Cases
• Non-Hodgkin's Lymphoma Age-specific Incident Cases
• Non-Hodgkin's Lymphoma Treatable Cases of NHL by Line of Therapies
Download the report to understand which factors are driving Non-Hodgkin's Lymphoma epidemiology trends @ Non-Hodgkin's Lymphoma Prevalence- https://www.delveinsight.com/sample-request/non-hodgkins-lymphoma-nhl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Non-Hodgkin's Lymphoma Drugs Market
The Non-Hodgkin's Lymphoma Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Non-Hodgkin's Lymphoma signaling in Non-Hodgkin's Lymphoma are likely to uncover new therapeutic targets and further expand treatment options for patients.
Non-Hodgkin's Lymphoma Treatment Market Landscape
The Non-Hodgkin's Lymphoma treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Non-Hodgkin's Lymphoma has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about Non-Hodgkin's Lymphoma treatment guidelines, visit @ Non-Hodgkin's Lymphoma Treatment Market Landscape- https://www.delveinsight.com/sample-request/non-hodgkins-lymphoma-nhl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Non-Hodgkin's Lymphoma Market Outlook
The report's outlook on the Non-Hodgkin's Lymphoma market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Non-Hodgkin's Lymphoma therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Non-Hodgkin's Lymphoma drug and late-stage pipeline therapy.
Non-Hodgkin's Lymphoma Drugs Uptake
The drug chapter of the Non-Hodgkin's Lymphoma report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Non-Hodgkin's Lymphoma.
Major Non-Hodgkin's Lymphoma Companies
GAbbVie, Genmab, Novartis, Angiocrine Bioscience, Autolus, Zentera Therapeutics, Jiangsu Hengrui Medicine, and others.
Learn more about the FDA-approved drugs for Non-Hodgkin's Lymphoma @ Drugs for Non-Hodgkin's Lymphoma Treatment- https://www.delveinsight.com/sample-request/non-hodgkins-lymphoma-nhl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Non-Hodgkin's Lymphoma Market Report
• Coverage- 7MM
• Non-Hodgkin's Lymphoma Companies- GAbbVie, Genmab, Novartis, Angiocrine Bioscience, Autolus, Zentera Therapeutics, Jiangsu Hengrui Medicine, and others.
• Non-Hodgkin's Lymphoma Therapies- Tisagenlecleucel, AB-205, Epcoritamab, AUTO4, ZN-d5, HRS-3738, and others.
• Non-Hodgkin's Lymphoma Market Dynamics: Non-Hodgkin's Lymphoma Market Drivers and Barriers
• Non-Hodgkin's Lymphoma Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Non-Hodgkin's Lymphoma Drugs in development @ Non-Hodgkin's Lymphoma Clinical Trials Assessment- https://www.delveinsight.com/sample-request/non-hodgkins-lymphoma-nhl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Report Introduction
3. Non-Hodgkin's Lymphoma Market Overview at a Glance
4. Executive Summary of Non-Hodgkin's Lymphoma
5. Key Events
6. Epidemiology and Market Methodology
7. Disease Background and Overview
8. Epidemiology and Patient Population
9. Patient Journey
10. Marketed Therapies
11. Emerging Therapies
12. Non-Hodgkin's Lymphoma: Market Analysis
13. KOL Views
14. SWOT Analysis
15. Unmet Needs
16. Market Access
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight
List of Top Selling Market Research Reports in 2025
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Lactose intolerance market- https://www.delveinsight.com/report-store/lactose-intolerance-market
Urea cycle disorders market- https://www.delveinsight.com/blog/urea-cycle-disorder-market
Overactive bladder syndrome market- https://www.delveinsight.com/report-store/underactive-bladder-market
Surgical energy instruments market- https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
Pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
Total knee arthroplasty market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Indwelling catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Surgical robotic system market- https://www.delveinsight.com/report-store/surgical-robotic-system-market
Surgical sealant market - https://www.delveinsight.com/report-store/surgical-sealant-and-adhesives-market
Novel drug delivery devices market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Healthcare competitive benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Ventral hernia market- https://www.delveinsight.com/report-store/hernia-repair-devices-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
Trichotillomania market- https://www.delveinsight.com/sample-request/trichotillomania-ttm-market
Medical marijuana market- https://www.delveinsight.com/blog/medical-marijuana-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Hodgkin lymphoma Treatment Market Size in the 7MM is expected to grow by a significant CAGR by 2032, estimates DelveInsight | AbbVie, Genmab, Novartis, Angiocrine Bioscience, Autolus, Zentera Therapeutics, Jiangsu Hengrui Medicine here
News-ID: 3894662 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Hodgkin
Hodgkin Lymphoma Treatment Market Poised to Reach USD 15.70 Bn by 2030 at 8.3% C …
Opening Paragraph
According to a new report by Maximize Market Research, the global Hodgkin Lymphoma Treatment Market was valued at USD 8.98 billion in 2023 and is projected to reach nearly USD 15.70 billion by 2030, growing at a CAGR of 8.3%.
Curious to peek inside? Grab your sample copy of this report now:https://www.maximizemarketresearch.com/request-sample/124690/
Key Highlights
Market Size & CAGR: Valued at USD 8.98 Bn in 2023, forecast to grow to USD 15.70…
High Prevalence Of Non-Hodgkin Lymphoma Fuels Market Growth: The Driving Engine …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Non Hodgkin Lymphoma (NHL) Market Size Growth Forecast: What to Expect by 2025?
The market size for non hodgkin lymphoma (NHL) has consistently seen robust growth in recent times. It is anticipated to expand from $10.11 billion in 2024 to $11.01 billion in 2025, with a compound annual growth…
Breakthrough Treatments for Non-Hodgkin Lymphoma
The Business Research Company recently released a comprehensive report on the Global Non Hodgkin Lymphoma (NHL) Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The non hodgkin…
Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight
The market for Non Hodgkin Lymphoma has significant unmet medical necessities in terms of demand for innovative drugs and novel technologies. This is one of the major factors behind the market witnessing rapid growth in Non Hodgkin Lymphoma segment. Past few decades have witnessed an increased level of activity with regards to development of new identification systems and drug mechanisms. In recent years, there have been an increasing number of…
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2017 | Market R …
Market Research Hub (MRH) has recently published a latest market study to its online portal, which is titled as “Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2017” This study offers professional analysis of the current state of Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Market.
Request Free Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1049067
Market Research HUB’s latest Pharmaceutical and Healthcare disease pipeline guide Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Pipeline Review, H1 2017, provides…
Non-Hodgkin Lymphoma - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Non-Hodgkin Lymphoma - Heat Map and Analysis to its growing collection of premium market research reports.
Non-Hodgkin lymphomas (NHL) are a heterogeneous group of malignancies that originate from lymphoid tissue, with varied clinical and biological features. There were an estimated 385,741 new cases of NHL and 199,630 deaths from NHL worldwide in 2012. NHLs are classified as either indolent (slow-growing)…
